Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients ...

Johnson & Johnson (JNJ) reports a Phase 3 success for its anti-inflammatory drug Tremfya in treating psoriatic arthritis.

Headquartered in New Brunswick, New Jersey, Johnson & Johnson (JNJ) researches and develops, manufactures, and sells various ...

Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a ...

Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank of Canada in a research note issued on Wednesday,Benzinga reports. They currently have a ...

Johnson & Johnson JNJ and Pfizer PFE are two of the world’s largest pharmaceutical companies with diversified healthcare ...

Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as ...

The conservative-backed loser of Wisconsin's Supreme Court election promptly conceded the race as it was called, angering his ...

U.S. Bankruptcy Court Judge Christopher Lopez in the Southern District of Texas rejected a request from Johnson & Johnson's (NYSE:JNJ) subsidiary, Red River Talc, to approve its prepackaged bankruptcy ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby ...

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...